| Metric | FY 2024 | Prior Q | FY 2023 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $480M | — | — | — | — |
| Op. Income | $125M | — | — | — | — |
| Gross Margin | 94.9% | — | — | — | — |
| Net Margin | 26.4% | — | — | — | — |
| EPS (Diluted) | $16.84 | — | — | — | — |
| Free Cash Flow | $176M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $480M |
| Cost of Revenue | $24M |
| GROSS PROFIT | $456M |
| R&D Expenses | $34M |
| Selling & Marketing | $255M |
| General & Administrative | $42M |
| SG&A Expenses | $296M |
| Other Expenses | $0 |
| Operating Expenses | $330M |
| Cost & Expenses | $354M |
| OPERATING INCOME | $125M |
| Interest Income | $4M |
| Interest Expense | $0 |
| Other Income/Expenses | $5M |
| INCOME BEFORE TAX | $130M |
| Income Tax Expense | $4M |
| Net Income from Continuing Ops | $127M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $127M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $127M |
| D&A | $2M |
| EBIT | $125M |
| EBITDA | $128M |
| EPS | $17 |
| EPS Diluted | $17 |
| Item | Amount |
|---|---|
| REVENUE | $480M |
| Cost of Revenue | $24M |
| GROSS PROFIT | $456M |
| R&D Expenses | $34M |
| Selling & Marketing | $255M |
| General & Administrative | $42M |
| SG&A Expenses | $296M |
| Other Expenses | $0 |
| Operating Expenses | $330M |
| Cost & Expenses | $354M |
| OPERATING INCOME | $125M |
| Interest Income | $4M |
| Interest Expense | $0 |
| Other Income/Expenses | $5M |
| INCOME BEFORE TAX | $130M |
| Income Tax Expense | $4M |
| Net Income from Continuing Ops | $127M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $127M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $127M |
| D&A | $2M |
| EBIT | $125M |
| EBITDA | $128M |
| EPS | $17 |
| EPS Diluted | $17 |
| Item | Amount |
|---|---|
| Net Income | $127M |
| Depreciation & Amortization | $2M |
| Stock-Based Compensation | $9M |
| Deferred Income Tax | $4M |
| Other Non-Cash Items | $195.8K |
| Change in Working Capital | $35M |
| OPERATING CASH FLOW | $176M |
| Capital Expenditure | -$488.2K |
| Acquisitions (Net) | $0 |
| Purchases of Investments | -$569M |
| Sales/Maturities of Investments | $547M |
| Other Investing Activities | $9.2K |
| NET CASH FROM INVESTING | -$23M |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | -$1M |
| NET CASH FROM FINANCING | -$1M |
| FREE CASH FLOW | $176M |
| Net Change in Cash | $153M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $278M |
| Short-Term Investments | $61M |
| Net Receivables | $38M |
| Inventory | $0 |
| Other Current Assets | $2M |
| TOTAL CURRENT ASSETS | $391M |
| PP&E (Net) | $4M |
| Goodwill | $0 |
| Intangible Assets | $8M |
| Long-Term Investments | $0 |
| Tax Assets | $1M |
| Other Non-Current Assets | $3M |
| TOTAL NON-CURRENT ASSETS | $16M |
| TOTAL ASSETS | $406M |
| Account Payables | $2M |
| Short-Term Debt | $0 |
| Deferred Revenue | $17M |
| Other Current Liabilities | $9M |
| TOTAL CURRENT LIABILITIES | $137M |
| Long-Term Debt | $0 |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $7M |
| Other Non-Current Liabilities | $500M |
| TOTAL NON-CURRENT LIABILITIES | $507M |
| TOTAL LIABILITIES | $645M |
| Common Stock | $10.4K |
| Additional Paid-In Capital | $29M |
| Retained Earnings | -$282M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $15M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | -$239M |
| Minority Interest | $0 |
| TOTAL EQUITY | -$239M |
| TOTAL LIABILITIES & EQUITY | $406M |
| Total Debt | $3M |
| Net Debt | -$276M |
